Omega Therapeutics is a biotech company leveraging epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines. The company uses highly selective and direct control of the human genome to treat and cure disease.

Register for Details

For more details on financing and valuation for Omega Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Updated on: May 17, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.